Suppr超能文献

相似文献

1
Emergence of VIM-12 in Enterobacter cloacae.
J Clin Microbiol. 2010 Sep;48(9):3414-5. doi: 10.1128/JCM.00843-10. Epub 2010 Jun 30.
2
Characterization of a new integron containing bla(VIM-1) and aac(6')-IIc in an Enterobacter cloacae clinical isolate from Greece.
J Antimicrob Chemother. 2005 May;55(5):634-8. doi: 10.1093/jac/dki073. Epub 2005 Mar 10.
5
Transmission and characterization of bla in Enterobacter cloacae at a teaching hospital in Yunnan, China.
Ann Clin Microbiol Antimicrob. 2017 Aug 22;16(1):58. doi: 10.1186/s12941-017-0232-y.
6
Molecular characterisation and diversity in Enterobacter cloacae from Edinburgh and Egypt carrying bla(CTX-M-14) and bla(VIM-4) β-lactamase genes.
Int J Antimicrob Agents. 2013 Jun;41(6):574-7. doi: 10.1016/j.ijantimicag.2013.02.012. Epub 2013 Apr 24.
8
Genetic and enzymatic properties of metallo-beta-lactamase VIM-5 from a clinical isolate of Enterobacter cloacae.
Antimicrob Agents Chemother. 2005 Oct;49(10):4400-3. doi: 10.1128/AAC.49.10.4400-4403.2005.
9
Multiclonal spread of VIM-1-producing Enterobacter cloacae isolates associated with In624 and In488 integrons located in an IncHI2 plasmid.
Int J Antimicrob Agents. 2014 May;43(5):451-5. doi: 10.1016/j.ijantimicag.2014.02.006. Epub 2014 Mar 20.
10
Characterization of pEncl-30969cz, a novel ColE1-like plasmid encoding VIM-1 carbapenemase, from an Enterobacter cloacae sequence type 92 isolate.
Diagn Microbiol Infect Dis. 2018 Jun;91(2):191-193. doi: 10.1016/j.diagmicrobio.2018.01.024. Epub 2018 Feb 2.

引用本文的文献

1
Distribution and Molecular Characterization of Functional Class 2 Integrons in Clinical Isolates.
Infect Drug Resist. 2022 Feb 16;15:465-474. doi: 10.2147/IDR.S347119. eCollection 2022.
2
MALDI-TOF MS Identification and Clustering Applied to Species in Nosocomial Setting.
Front Microbiol. 2018 Aug 14;9:1885. doi: 10.3389/fmicb.2018.01885. eCollection 2018.
3
Antibiotic combinations for controlling colistin-resistant Enterobacter cloacae.
J Antibiot (Tokyo). 2017 Feb;70(2):122-129. doi: 10.1038/ja.2016.77. Epub 2016 Jul 6.
4
Carbapenem Resistance among Enterobacter Species in a Tertiary Care Hospital in Central India.
Chemother Res Pract. 2014;2014:972646. doi: 10.1155/2014/972646. Epub 2014 Aug 10.

本文引用的文献

1
Infections with VIM-1 metallo-{beta}-lactamase-producing enterobacter cloacae and their correlation with clinical outcome.
J Clin Microbiol. 2009 Nov;47(11):3514-9. doi: 10.1128/JCM.01193-09. Epub 2009 Sep 9.
3
Clonal spread of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains in Greece.
J Antimicrob Chemother. 2009 Aug;64(2):348-52. doi: 10.1093/jac/dkp207. Epub 2009 Jun 13.
4
AmpC beta-lactamases.
Clin Microbiol Rev. 2009 Jan;22(1):161-82, Table of Contents. doi: 10.1128/CMR.00036-08.
7
Hidden VIM-1 metallo-beta-lactamase phenotypes among Acinetobacter baumannii clinical isolates.
J Clin Microbiol. 2008 Jan;46(1):346-9. doi: 10.1128/JCM.01670-07. Epub 2007 Nov 21.
8
First occurrence of an Escherichia coli clinical isolate producing the VIM-1/VIM-2 hybrid metallo-beta-lactamase VIM-12.
Antimicrob Agents Chemother. 2007 Aug;51(8):3038-9. doi: 10.1128/AAC.00374-07. Epub 2007 May 21.
10
VIM-12, a novel plasmid-mediated metallo-beta-lactamase from Klebsiella pneumoniae that resembles a VIM-1/VIM-2 hybrid.
Antimicrob Agents Chemother. 2005 Dec;49(12):5153-6. doi: 10.1128/AAC.49.12.5153-5156.2005.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验